z-logo
open-access-imgOpen Access
Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in the Treatment of Patients with Advanced Primary Hepatocellular Carcinoma: A Retrospective, Real-World Study in China
Author(s) -
Xiao-Qi Chen,
Yun-Xia Zhao,
Chuanlei Zhang,
Xinting Wang,
Xin Zhang,
Xi Chen,
Chang-Wei Yuan,
Qing Zhao,
Xinju Chen
Publication year - 2022
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s358092
Subject(s) - medicine , clinical endpoint , hepatocellular carcinoma , retrospective cohort study , gastroenterology , adverse effect , oncology , surgery , clinical trial

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here